Oncology Clinical Trials in Kansas City, MO

As of June 2026, 101 paid clinical trials are recruiting for Oncology in Kansas City, Missouri. Oncology trials evaluate immunotherapies, targeted therapies, antibody-drug conjugates, and combination regimens across solid tumors and blood cancers — from early-phase first-in-human studies to phase 3 registration trials. Compensation typically covers time, travel, and study visits, and many studies also include study-related medical care at no cost.

Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: June 12, 2026.

Filter results

Filter results

State

City

Facility

Phase

Study type

Intervention

Recruitment status

Condition

Sex

Age

Healthy volunteers only

101 clinical trials for Oncology

·Clear filters·↓ Download CSV

Testing Early Treatment for Patients With High-Risk Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Leukemia (SLL), EVOLVE CLL/SLL Study

for Chronic Lymphocytic Leukemia

621 locations incl. Birmingham

Sponsor: National Cancer Institute (NCI)

Sex: All·Age: 18+

Code: NCT04269902·Phase 3·Recruiting

Apply to this trial

Beat Childhood Cancer Specimen Banking and Data Registry

for Pediatric Cancer

18 locations incl. Little Rock

Sponsor: Giselle Sholler

Sex: All·Age: All ages·Accepts healthy volunteers

Code: NCT04715178·Recruiting

Apply to this trial

Eflornithine (DFMO) and Etoposide for Relapsed/Refractory Neuroblastoma

for Neuroblastoma

25 locations incl. Birmingham

Sponsor: Giselle Sholler

Sex: All·Age: Up to 31

Code: NCT04301843·Phase 2·Recruiting

Apply to this trial

A Safety Study of SEA-CD70 in Patients With Myeloid Malignancies

for Myelodysplastic Syndrome

49 locations incl. Birmingham

Sponsor: Seagen, a wholly owned subsidiary of Pfizer

Sex: All·Age: 18+

Code: NCT04227847·Phase 1·Recruiting

Apply to this trial

A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patients With Newly Diagnosed AML With or Without FLT3 Mutations

for Acute Myeloid Leukemia

185 locations incl. Birmingham

Sponsor: Children's Oncology Group

Sex: All·Age: Up to 21

Code: NCT04293562·Phase 3·Recruiting

Apply to this trial

Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])

for Lung Non-Small Cell Carcinoma

1150 locations incl. Anchorage

Sponsor: National Cancer Institute (NCI)

Sex: All·Age: 18+

Code: NCT04267848·Phase 3·Recruiting

Apply to this trial

Testing the Addition of the Drug Apalutamide to the Usual Hormone Therapy and Radiation Therapy After Surgery for Prostate Cancer, INNOVATE Trial

for Prostate Adenocarcinoma

Drug: Apalutamide

345 locations incl. Phoenix

Sponsor: NRG Oncology

Sex: Male·Age: 18+

Code: NCT04134260·Phase 3·Recruiting

Apply to this trial

A Master Protocol (LY900023) That Includes Several Clinical Trials of Drugs for Children and Young Adults With Cancer

for Neoplasms

30 locations incl. Birmingham

Sponsor: Eli Lilly and Company

Sex: All·Age: 1 - 39

Code: NCT05999994·Phase 2·Recruiting

Apply to this trial

Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy

for B Acute Lymphoblastic Leukemia

203 locations incl. Birmingham

Sponsor: Children's Oncology Group

Sex: All·Age: 365 Days - 25

Code: NCT03959085·Phase 3·Recruiting

Apply to this trial

Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO

for Autoimmune Disease

Drug: Nivolumab

51 locations incl. Birmingham

Sponsor: National Cancer Institute (NCI)

Sex: All·Age: 18+

Code: NCT03816345·Phase 1·Recruiting

Apply to this trial

Regional Radiotherapy in Biomarker Low-Risk Node Positive and T3N0 Breast Cancer

for Breast Cancer

451 locations incl. Fairbanks

Sponsor: Canadian Cancer Trials Group

Sex: Female·Age: 35+

Code: NCT03488693·Phase 3·Recruiting

Apply to this trial

Testing the Addition of 131I-MIBG or Lorlatinib to Intensive Therapy in People With High-Risk Neuroblastoma (NBL)

for Ganglioneuroblastoma

152 locations incl. Birmingham

Sponsor: Children's Oncology Group

Sex: All·Age: 365 Days - 30

Code: NCT03126916·Phase 3·Recruiting

Apply to this trial

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

for Cancer, Metastatic

67 locations incl. Birmingham

Sponsor: Massive Bio, Inc.

Sex: All·Age: All ages

Code: NCT03452774·Recruiting

Apply to this trial

Neuroblastoma Maintenance Therapy Trial

for Neuroblastoma

42 locations incl. Birmingham

Sponsor: Giselle Sholler

Sex: All·Age: 1 - 30

Code: NCT02679144·Phase 2·Recruiting

Apply to this trial

Project: Every Child for Younger Patients With Cancer

for Adrenal Gland Pheochromocytoma

245 locations incl. Birmingham

Sponsor: Children's Oncology Group

Sex: All·Age: Up to 25

Code: NCT02402244·Recruiting

Apply to this trial

Pediatric Precision Laboratory Advanced Neuroblastoma Therapy

for Neuroblastoma

24 locations incl. Birmingham

Sponsor: Giselle Sholler

Sex: All·Age: Up to 22

Code: NCT02559778·Phase 2·Recruiting

Apply to this trial

Integrated Cancer Repository for Cancer Research

for Pancreatic Cancer

42 locations incl. Greenwood Village

Sponsor: University of Nebraska

Sex: All·Age: 19 - 110·Accepts healthy volunteers

Code: NCT02012699·Recruiting

Apply to this trial

A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)

for Hematologic Malignancies

142 locations incl. Birmingham

Sponsor: Center for International Blood and Marrow Transplant Research

Sex: All·Age: All ages

Code: NCT01351545·Recruiting

Apply to this trial

Triple Negative Breast Cancer and Germline Hereditary Breast and Ovarian Cancer Mutation Carrier Registry

for Breast Cancer

11 locations incl. Hays

Sponsor: University of Kansas Medical Center

Sex: All·Age: All ages·Accepts healthy volunteers

Code: NCT02302742·Recruiting

Apply to this trial

Barrett's Esophagus Related Neoplasia (BERN) Project

for Barrett's Esophagus

1 location in Kansas City

Sponsor: Midwest Biomedical Research Foundation

Sex: All·Age: 18+

Code: NCT00590239·Recruiting

Apply to this trial

Progression of Gastroesophageal Reflux Disease and Barrett's Esophagus and the Creation of a Barrett's Registry

for Barrett's Esophagus

1 location in Kansas City

Sponsor: Midwest Biomedical Research Foundation

Sex: All·Age: 18+·Accepts healthy volunteers

Code: NCT00574327·Recruiting

Apply to this trial

Conditions in Oncology (Kansas City, MO)

Breast cancer· 22 Non-small cell lung cancer (NSCLC)· 15 Solid tumor· 12 Metastatic breast cancer· 7 Acute myeloid leukemia (AML)· 7 Neuroblastoma· 7 Myelodysplastic syndromes (MDS)· 6 Hematologic malignancy· 6 Cancer (any)· 6 Prostate cancer· 5 Chronic lymphocytic leukemia (CLL)· 5 Non-Hodgkin lymphoma· 5 Lung cancer· 4 Gastroesophageal junction cancer· 4 Ovarian cancer· 4 Leukemia (other)· 4 Small lymphocytic lymphoma· 4 Melanoma· 4 Colorectal cancer· 3 Esophageal cancer· 3 Endometrial cancer· 3 Glioblastoma· 3 Multiple myeloma· 3 Diffuse large B-cell lymphoma (DLBCL)· 3 Metastatic colorectal cancer· 2 Pancreatic cancer· 2 Gastric cancer· 2 Liver cancer· 2 Biliary tract cancer· 2 Metastatic prostate cancer· 2 Bladder cancer· 2 Acute lymphoblastic leukemia· 2 Myeloproliferative neoplasm· 2 Hodgkin lymphoma· 2 Mantle cell lymphoma· 2 Sarcoma· 2 Osteosarcoma· 2 Ewing sarcoma· 2 Neuroendocrine tumors· 2 HER2-positive breast cancer· 1 Colon cancer· 1 Rectal cancer· 1 Kidney cancer· 1 Fallopian tube cancer· 1 Brain cancer· 1 Myelofibrosis· 1 Follicular lymphoma· 1 Marginal zone lymphoma· 1 Burkitt lymphoma· 1 Skin cancer· 1 Thyroid cancer· 1 Rhabdomyosarcoma· 1 Pediatric cancer· 1 Mesothelioma· 1